(July 1, 2020, 10:00 AM EDT) -- NEW YORK — Drug maker Pfizer Inc. on June 26 sued the U.S. Department of Health and Human Services and its inspector general, seeking a declaratory judgment by a New York federal court that a proposed drug co-pay program does not violate federal kickback and inducement restrictions (Pfizer Inc. v. U.S. Department of Health and Human Services, et al., No. 20-4920, S.D. N.Y.)....